Cervical Cancer Prevention, Its Challenges and Solutions in Iran and Worldwide: A Systematic Review
Background: Widespread use of screening in high-income countries has led to significant reductions in mortality from cervical cancer. However, in Iran, the main reason for the late diagnosis of cervical cancer was the failure to perform a Pap smear (Papanicolaou). We aimed to investigate the status of cervical cancer prevention and its challenges and solutions in Iran.
Method: We conducted a systematic review of literature published from 1974 to 2021 in the electronic databases, including PubMed, Web of Science, Embase, Scopus, and Google Scholar, and retrieved all English-language articles. Following the application of the inclusion and exclusion criteria, full-text articles were identified and evaluated for eligibility. Finally, these publications were analyzed as part of the synthesis.
Results: Lower social-economic level, inadequate knowledge of screening tests and health centers for Pap test performance leading to worse outcomes such as lower screening participation or coverage.
Conclusion: By addressing these challenges through increasing education, increasing service accessibility, expanding screening programs, improving public awareness, improving insurance coverage, and establishing a control protocol for follow-up, it is possible to reduce cervical cancer incidence and mortality.
2. WHO. Early Diagnosis and Screening [Internet]. WHO. 2018 [cited September 24, 2019]. Available from: https://www.who.int/cancer/prevention/diagnosis-screening/cervical-cancer/en/.
3. WHO. Global Health Observatory data repository, By category, Noncommunicable diseases,Mortality, Risk of premature death from the four target NCDs, Data by country, Global Health Observatory visualizations, Cervical cancer screening. [Internet]. Geneva: WHO; 2016 [updated 2019. Available from: http://apps.who.int/gho/data/node.wrapper.imr?x-id=3354
4. IARC. World cancer report 2008 [Internet]. IARC Press. 2008 [cited March 6, 2019]. Available from: https://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2008.
5. Mousavi S (2006). Mousavi, SM. Comprehensive National Cancer Control Program in the Islamic Republic of Iran. 2015 edn. Ministry of Health and Medical Education, Deputy of Health, Disease Management Center, Cancer Office, Tehran.
6. Khorasanizadeh F, Hassanloo J, Khaksar N,et al (2013). Epidemiology of cervical cancer and human papilloma virus infection among Iranian women - analyses of national data and systematic review of the literature. Gynecol Oncol, 128(2):277-81.
7. Amin R, Kolahi AA, Jahanmehr N, Abadi AR, Sohrabi MR (2020). Disparities in cervical cancer screening participation in Iran: a cross-sectional analysis of the 2016 nationwide STEPS survey. BMC Public Health, 20(1):1594.
8. Moher D, Altman DG, Liberati A, Tetzlaff J (2011). PRISMA statement. Epidemiology, 22:128.
9. Abdullahi LH, Hussey GD, Wiysonge CS, Kagina BM (2020). Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives. S Afr Med J, 110(6):525-531.
10. Abedian Z, Dar Mohammadi M (2013). Survey of knowledge, attitude and practice of women referring to health centers in Mashhad about Pap smear in 2009. Iranian Journal of Obstetrics, Gynecology and Infertility, 15:22-28.
11. Ahmadi R, Karimi Harouni R, Aflak Sir AA (2017). Evaluation of knowledge and attitude of women employees in Shiraz about cervical cancer and Pap smear test. The 4th International Conference on Recent Innovations in Psychology, Counseling and Behavioral Sciences, undefined,
12. Ahmadipour H, Sheikhizade S (2016). Breast and Cervical Cancer Screening in Women Referred to Urban Healthcare Centers in Kerman, Iran, 2015. Asian Pac J Cancer Prev, 17(S3):143-7.
13. Akbari H, Jedi Arani T, Gilasi H, et al (2014). Study of motivational factors and causes of nonparticipation to breast and cervical cancer screening tests among women attending health centers in Kashan city. Journal of Ilam University of Medical Sciences, 22:137-148.
14. Alam M, Mohammad Alizadeh S, Aflatonian MR, Azizzadeh Forouzi M (2007). A survey of knowledge, attitude and practice of health workers in Kerman province in the field of Pap smear test. Medical Journal of Hormozgan 10:379. [In Persian].
15. Allahverdipour H, Emami A (2008). Perceptions of cervical cancer threat, benefits, and barriers of Papanicolaou smear screening programs for women in Iran. Women Health, 47(3):23-37.
16. Amarin Z, Khader Y, Okour A, Jaddou H, Al‐Qutob R (2010). National maternal mortality ratio for Jordan, 2007–2008. Int J Gynaecol Obstet, 111(2):152-156.
17. Arrossi S, Paolino M, Sankaranarayanan R (2010). Challenges faced by cervical cancer prevention programs in developing countries: a situational analysis of program organization in Argentina. Rev Panam Salud Publica, 28(4):249-57.
18. Ashtarian HP, Mirzabeigi EB, Mahmoodi EB, Khezeli MP (2017). Knowledge about Cervical Cancer and Pap Smear and the Factors Influencing the Pap test Screening among Women. Int J Community Based Nurs Midwifery, 5(2):188-195.
19. Bahmani A, Baghianimoghadam MH, Enjezab B, Mazloomy Mahmoodabad SS, Askarshahi M (2015). Factors Affecting Cervical Cancer Screening Behaviors Based On the Precaution Adoption Process Model: A Qualitative Study. Glob J Health Sci, 8(6):211-8.
20. Bakht R, Shabairi F, ghodratollah r, Fakuri E (2016). The factors affecting cervical cancer screening among addicted women of Hamedan in 2015: On the basis of Protection Motivation Theory model. Jorjani Biomedicine Journal, 4:68-80.
21. Batson A, Meheus F, Brooke S (2006). Chapter 26: Innovative financing mechanisms to accelerate the introduction of HPV vaccines in developing countries. Vaccine, 24 Suppl 3:S3/219-25.
22. Bayrami R, Taghipour A, Ebrahimipour H (2014). Challenges of providing cervical cancer prevention programs in Iran: A qualitative study. Asian Pac J Cancer Prev, 15(23):10071-10077.
23. Bayrami R, Taghipour A, Ebrahimipour H (2015). Personal and socio-cultural barriers to cervical cancer screening in Iran, patient and provider perceptions: a qualitative study. Asian Pac J Cancer Prev, 16(9):3729-34.
24. Daryani S, Shojaeezadeh D, Batebi A, Charati JY, Naghibi A (2016). The effect of education based on a health belief model in women's practice with regard to the Pap smear test. J Cancer Policy, 8:51-56.
25. De Brouwere V, Tonglet R, Van Lerberghe W (1998). Strategies for reducing maternal mortality in developing countries: what can we learn from the history of the industrialized West? Trop Med Int Health, 3(10):771-82.
26. Dochez C, Al Awaidy S, Mohsni E, Fahmy K, Bouskraoui M (2020). Strengthening national teams of experts to support HPV vaccine introduction in Eastern Mediterranean countries: Lessons learnt and recommendations from an international workshop. Vaccine, 38:1114-1119.
27. Eghbal SB, Karimy M, Kasmaei P, Roshan ZA, Valipour R, Attari SM (2020). Evaluating the effect of an educational program on increasing cervical cancer screening behavior among rural women in Guilan, Iran. BMC Womens Health, 20(1):149.
28. Enjezab B, Faraj khoda T, Mojahed S, Bokaee M (2004). Barriers and Motivators Related to Cervical and Breast Cancer Screening. The Journal of Shahid Sadoughi University of Medical Sciences, 12:78-84.
29. Gahremani Nasab P, Shahnazi M, Farshbaf Khalili A, Ganbari S (2014). Factors Related to Cervical Cancer Screening among Women Referring to Health Centers in Tabriz, Iran 2012. Iranina Journal of Obstetrics Gynecology and Infertility, 16:15-24.
30. Ghahramani M, Alami A, Mohammad Zade Moghaddam H, Moodi M (2018). Screening for Cervical Cancer: An Educational Intervention Based on Transtheoretical Models and Health Belief in Women of Gonabad, Iran. Iranina Journal of Obstetrics Gynecology and Infertility, 21:22-32. [In Persian].
31. Ghaoomi M, Aminimoghaddam S, Safari H, Mahmoudzadeh A (2016). Awareness and practice of cervical cancer and Pap smear testing in a teaching hospital in Tehran. Tehran University Medical Journal, 74:183-189.
32. Glanz K, Bishop DB (2010). The role of behavioral science theory in development and implementation of public health interventions. Annu Rev Public Health, 31:399-418.
33. Hajializadeh K, Ahadi H, Jomehri F, Rahgozar M (2014). The Role of Health Beliefs in Predicting Barriers to Cervical Cancer Screening. Journal of Kerman University of Medical Sciences, 21:416. [In Persian].
34. Hendry M, Lewis R, Clements A, Damery S, Wilkinson C (2013). "HPV? Never heard of it!": a systematic review of girls' and parents' information needs, views and preferences about human papillomavirus vaccination. Vaccine, 31(45):5152-67.
35. Jalalvandi M, Khodadoostan M (2005). Married Women And Pap Smear, What They Know? How They Do? Iran Journal of Nursing, 18:139-144.
36. Jumaan AO, Ghanem S, Taher J, Braikat M, Awaidy SA, Dbaibo GS (2013). Prospects and challenges in the introduction of human papillomavirus vaccines in the extended middle east and North Africa Region. Vaccine, 31 Suppl 6:G58-G64.
37. Kasmaei P, Bab Eghbal S, Atrkare Roshan Z, Estebsari F, Mehrabian F, Karimi M (2014). The effect of health belief model on rural women's Pap smear test. Nursing and Midwifery Journal, 12:401-408.
38. Keshavarz Z, Simbar M, Ramezankhani A (2011). Factors for performing breast and cervix cancer screening by Iranian female workers: a qualitative-model study. Asian Pac J Cancer Prev, 12(6):1517-22.
39. Keshavarz Z, Simbar M, Ramezankhani A, Alavi Majd H (2012). Factors influencing the behavior of female-workers in the reproductive age regarding breast and cervical cancer screening based on the Integrated Model of Planned Behavior and Self-Efficacy: A qualitative approach. Journal of School of Public Health and Institute of Public Health Research, 9:23-36.
40. Keshavarzian K, Barzegari Z (2014). Awareness and practice of women referring to Harris County Health Centers about cervical cancer and Pap smear. Med J Tabriz Uni Med Sciences Health Services, 36:70-73.
41. Khojasteh F (2004). Evaluation of knowledge, attitude and practice of women referring to health centers in Zahedan about Pap smear and cervical cancer. Jundishapur Scientific Medical Journal, -:1-9. [In Persian].
42. Levano W, Miller JW, Leonard B, et al (2014). Public education and targeted outreach to underserved women through the National Breast and Cervical Cancer Early Detection Program. Cancer, 120 Suppl 16(0 16):2591-6.
43. Luciani S, Vardy L, Paci E, Adewole I, Sasco A, Calvacante T (2009). Cancer prevention and population-based screening. Tumori, 95(5):597-609.
44. Majidi A, Ghiasvand R, Hadji M, et al (2016). Priority Setting for Improvement of Cervical Cancer Prevention in Iran. Int J Health Policy Manag, 5(4):225-32.
45. Majidi A, Majidi S, Salimzadeh S, et al (2017). Cancer Screening Awareness and Practice in a Middle Income Country; A Systematic Review from Iran. Asian Pac J Cancer Prev, 18(12):3187-3194.
46. Maseko FC, Chirwa ML, Muula AS (2015). Health systems challenges in cervical cancer prevention program in Malawi. Glob Health Action, 8:26282.
47. Moore MA, Eser S, Igisinov N, et al (2010). Cancer epidemiology and control in North-Western and Central Asia - past, present and future. Asian Pac J Cancer Prev, 11 Suppl 2:17-32.
48. Nahvijou A, Hadji M, Marnani AB, et al (2014). A systematic review of economic aspects of cervical cancer screening strategies worldwide: discrepancy between economic analysis and policymaking. Asian Pac J Cancer Prev, 15(19):8229-37.
49. Onsory K, Zandi G, Abdollahi M, Seyri Foroun Abad M (2014). Knowledge and awareness of Pap smear screening among Parand and Robat-Karim women. New Cellularand Molecular Biotechnology Journal, 4:93-98.
50. Pakseresht S, Jafarzadeh-Kenarsari F, Rafat F, Rahebi SM (2016). Exploration of Women's Perspective on Cervical Cancer: A Qualitative Study. Journal of Holistic Nursing and Midwifery, 26:43-51.
51. Parsa P, Sharifi F, Shobeiri F, Karami M (2017). Effects of Group Counseling Based on Health Belief Model on Cervical Cancer Screening Beliefs and Performance of Rural Women in Kaboudrahang, Iran. Asian Pac J Cancer Prev, 18(6):1525-1530.
52. Pirzadeh A, Mazaheri MA (2012). The Effect of Education on Women's Practice Based on the Health Belief Model About Pap Smear Test. Int J Prev Med, 3(8):585-90.
53. Pourkazemi A, Ghanbari A, Fakour F, Ghorbani S (2017). Knowledge and Attitudes of Medical Students Toward Human Papilloma Virus in Rasht, 2013. Journal of Guilan University of Medical Sciences, 25:1-10.
54. Rakhshani F, Jalilian F, Mirzaei Alavijeh M, et al (2013). Pap smear test among Women: An Educational Intervention Based on Health Belief Model .Journal of Birjand University of Medical Sciences, 20:136-143.
55. Saberi F, Sadat Z, Abedzadeh M (2012). Factors associated with cervical cancer screening and its barriers among women: Kashan, Iran. Health Monitor Journal of the Iranian Institute for Health Sciences Research, 11:365-370.
56. Shafti V, Galandari M (2017). Knowledge about Pap smear test, cervical cancer and human papilloma virus among women referred to Gynecology Clinic of Tonekabon Shahid Rajaei Hospital in 2016. Medical Sciences Journal, 27:294-300.
57. Shah Hosseini Z, Babapour F (2019). A review of Iranian women's knowledge and attitudes toward human papillomavirus and vaccination against it and its relationship with cervical cancer. (ed)^(eds) 8th National Conference on Health Promotion Strategies and Challenges (Focusing on Cancer), undefined, pp. [In Persian].
58. Sharifi M, Mohammadi Z, Makvandi Z, Rostami P, Moradi A (2018). Assessment of cervical cancer screening and its barriers in 18-50 year old women referring to Asad Abad comprehensive health centers . Pajouhan Scientific Journal, 16:35-45. [In persian].
59. Shirazi Zadeh Mehraban S, Namdar A, Naghizadeh MM (2018). Assessment of Preventive Behavior for Cervical Cancer with the Health Belief Model. Asian Pac J Cancer Prev, 19(8):2155-2163.
60. Shojaeizadeh D, Hashemi SZ, Moeini B, Poorolajal J (2011). The Effect of Educational Program on Increasing Cervical Cancer Screening Behavior among Women in Hamadan, Iran: Applying Health Belief Model. J Res Health Sci, 11(1):20-5.
61. Simbar M, Ghazanfarpour M, Abdolahian S (2020). Effects of training based on the health belief model on Iranian women's performance about cervical screening: A systematic review and meta-analysis. J Educ Health Promot, 9:179.
62. Soltanizadeh N, Ameri Shahrabi M, Kavousy E, Hashemi SM (2021). Pathological probing in the health culture focusing on Human Papillomavirus (HPV) diseases. Pejouhesh Dar Pezeshki (Research in Medicine), 45:52-59.
63. Tabeshian A, Firozeh F (2009). The effect of health education on performing Pap smear test for prevention of cervix cancer in teachers of Isfahan city. Medical Science Journal of Islamic Azad Univesity Tehran Medical Branch, 19:43.
64. Taghizadeh Asl R, Van Osch L, De Vries N, et al (2020). The role of knowledge, risk perceptions, and cues to action among Iranian women concerning cervical cancer and screening: a qualitative exploration. BMC Public Health, 20(1):1688.
65. Thulaseedharan JV, Frie KG, Sankaranarayanan R (2019). Challenges of health promotion and education strategies to prevent cervical cancer in India: A systematic review. J Educ Health Promot, 8:216.
66. Wang A, Pollack T, Kadziel LA, et al (2018). Impact of Practice Facilitation in Primary Care on Chronic Disease Care Processes and Outcomes: a Systematic Review. J Gen Intern Med, 33(11):1968-1977.
67. Wang SM, Qiao YL (2015). Implementation of cervical cancer screening and prevention in China--challenges and reality. Jpn J Clin Oncol, 45(1):7-11.
68. Weinmann S, Naleway A, Swamy G, et al (2017). Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational Study. PLoS One, 12(1):e0165276.
69. WHO (2014). Comprehensive cervical cancer control: A guide to essential practice. (ed)^(eds), 2006 edn. Department of Reproductive Health and Research World Health Organization, Geneva.
70. Wigle J, Coast E, Watson-Jones D (2013). Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects. Vaccine, 31(37):3811-3817.
71. Zareai M (2014). Women’s knowledge and practice of Pap smear test and barriers to performing it in Jahrom. Pars of Jahrom University of Medical Sciences, 12:37-45.
72. zendehdel K (2013). Compiling a report on cervical cancer prevention status and presenting suggestions and priorities for developing a national cervical cancer prevention program in Iran. Cancer Research Center, Cancer Institute of Iran, Tehran.
73. Kasraeian M, Hessami K, Vafaei H, et al (2020). Patients' self-reported factors influencing cervical cancer screening uptake among HIV-positive women in low- and middle-income countries: An integrative review. Gynecol Oncol Rep, 33:100596.
74. Refaei M, Nayeri ND, Khakbazan Z, Pakgohar M (2017). Cervical cancer screening in Iranian women: Healthcare practitioner perceptions and views. Asian Pac J Cancer Prev, 18(2):357-363.
75. Keyhani E, Kohannia N, Izadimood N, Keyhkhaee MR, Najmabadi H (2006). The prevalence of human papilloma virus(HPV)in malignant cervical lesion, using multiplex PCR. Tehran University Medical Journal,64(3):95-101.
76. Nahvijou A, Daroudi R, Tahmasebi M, et al (2016). Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer. PLoS One, 11(6):e0156705.
77. Sargazi N, Takian A, Daroudi R, et al (2022). Cost–benefit Analysis of Human Papillomavirus Vaccine in Iran. J Prev(2022), 43(6):841–57.
|Issue||Vol 52 No 11 (2023)|
|Cervical cancer Prevention Challenges Systematic review Iran|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|